13.95SEK+5.28%Mkt Cap: 423.29M SEKP/E: —Last update: 2026-05-13
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, a…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)21.81
PEG—
P/B3.06
P/S1.52
EV/EBITDA-13.47
EV/Revenue1.19
EPS (TTM)-0.66
EPS (Forward)0.69
Cash Flow & Leverage
FCF Yield-7.66%
FCF Margin-11.62%
Operating CF-20.30M SEK
CapEx (TTM)15.46M SEK
Net Debt/EBITDA0.67
Net Debt-16.55M SEK
Technical
SMA 5013.29 (+5.0%)
SMA 20012.99 (+7.3%)
Beta0.46
S&P 52W Chg24.23%
Avg Vol (30d)22.66K
Avg Vol (10d)41.69K
Technical Indicators
RSI (14)63.1
MACD-0.0345
MACD Signal-0.1355
MACD Hist.+0.1009
BB Upper13.55 SEK
BB Middle12.94 SEK
BB Lower12.33 SEK
BB Width9.40%
ATR (14)0.5061 SEK
Vol Ratio (20d)0.46x
52W Range
8.50043% of range21.30
52W High21.30 SEK
52W Low8.500 SEK
Profitability
Gross Margin89.89%
EBITDA Margin-8.80%
Profit Margin-11.59%
Oper. Margin16.67%
ROE-23.37%
ROA-10.36%
Revenue Growth5.30%
Earnings Growth474.50%
Balance Sheet
Debt/Equity0.12
Current Ratio1.07
Quick Ratio0.90
Book Value/Sh4.920 SEK
Cash/Share1.187 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.28.13M
Float4.52M
Insiders50.96%
Institutions28.08%
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)21.00 SEK
Target Range13.50 SEK – 28.50 SEK
# Analysts2
Company
Market Cap423.29M SEK
Enterprise Value330.80M SEK
Revenue (TTM)279.09M SEK
Gross Profit250.87M SEK
Net Income (TTM)-32.33M SEK
Revenue/Share9.923 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees129
Last Price13.95 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—